Anna Nappi

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With <i>RAS</i> Wild-type Metastatic Colorectal Cancer

Erika Martinelli, Giulia Martini, Vincenzo Famiglietti et al. · JAMA Oncology · 2021 · 185 citations · Full text

Medicine, Oncology, Pharmacology +17

Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR–MET Interaction and Activation of MET Signaling in Colon Cancer Cells

Teresa Troiani, Erika Martinelli, Stefania Napolitano et al. · Clinical Cancer Research · 2013 · 145 citations · Full text

Medicine, Oncology, Pharmacology +17

Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition

Teresa Troiani, Stefania Napolitano, Donata Vitagliano et al. · Clinical Cancer Research · 2014 · 103 citations

Medicine, Oncology, Pharmacology +17

Parameter estimation of a static geotechnical model using a Bayes' approach

Annamaria Cividini, G. Maier, Anna Nappi · International Journal of Rock Mechanics and Mining Sciences & Geomechanics Abstracts · 1983 · 92 citations

Engineering, Civil Engineering, Earth Sciences +9

Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi‐targeted kinase inhibitors in pimasertib‐resistant human lung and colorectal cancer cells

Erika Martinelli, Teresa Troiani, Elena D’Aiuto et al. · International Journal of Cancer · 2013 · 91 citations · Full text

Medicine, Oncology, Pharmacology +15